| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-07-3256 |
| P698 | PubMed publication ID | 17974973 |
| P2093 | author name string | Murray Korc | |
| Tobias Götze | |||
| Arikira Matsushita | |||
| P2860 | cites work | Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer | Q40248519 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 10309-10316 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. | |
| P478 | volume | 67 |
| Q33694161 | Adipocytes enhance murine pancreatic cancer growth via a hepatocyte growth factor (HGF)-mediated mechanism |
| Q54576131 | Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner |
| Q42379626 | Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation |
| Q35206904 | Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars |
| Q55053381 | Clinical value of plasma hepatocyte growth factor measurement for the diagnosis of periampullary cancer and prognosis after pancreaticoduodenectomy |
| Q48949989 | Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling |
| Q40975840 | Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis. |
| Q40051841 | Distinct intracellular signaling mediates C-MET regulation of dendritic growth and synaptogenesis |
| Q41556287 | Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis |
| Q38056998 | Function of members of the neuropilin family as essential pleiotropic cell surface receptors. |
| Q34667822 | Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal Transition |
| Q36771302 | GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
| Q39557490 | Hepatocyte Growth Factor Inhibits Anoikis of Pancreatic Carcinoma Cells Through Phosphatidylinositol 3-Kinase Pathway |
| Q26781273 | Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge |
| Q36547939 | Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer |
| Q37958931 | How neuropilin-1 regulates receptor tyrosine kinase signalling: the knowns and known unknowns |
| Q54213024 | Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients |
| Q58738114 | Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer |
| Q34380517 | LDL Receptor-Related Protein 1 Regulates the Abundance of Diverse Cell-Signaling Proteins in the Plasma Membrane Proteome |
| Q41769754 | LY294002 induces differentiation and inhibits invasion of glioblastoma cells by targeting GSK-3beta and MMP |
| Q39644339 | Loss of tyrosine phosphatase‐dependent inhibition promotes activation of tyrosine kinase c‐Src in detached pancreatic cells |
| Q30394618 | MET-activating Residues in the B-repeat of the Listeria monocytogenes Invasion Protein InlB. |
| Q39949932 | Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2 |
| Q39380720 | Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI‐3 kinase/Akt |
| Q33884456 | Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells. |
| Q33808309 | Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis |
| Q92668799 | N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals |
| Q38087875 | Navigation rules for vessels and neurons: cooperative signaling between VEGF and neural guidance cues |
| Q92366518 | Neuropilin 1 modulates TGF‑β1‑induced epithelial‑mesenchymal transition in non‑small cell lung cancer |
| Q38165001 | Neuropilin 1: function and therapeutic potential in cancer |
| Q24647073 | Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity |
| Q38532037 | Neuropilin-1 as Therapeutic Target for Malignant Melanoma. |
| Q39615518 | Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta |
| Q30415837 | Neuropilin-1 in transplantation tolerance. |
| Q36825006 | Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity |
| Q36489958 | Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors |
| Q41478957 | Neuropilin-1 is upregulated by Wnt/β-catenin signaling and is important for mammary stem cells |
| Q47825349 | Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells. |
| Q24337623 | Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells |
| Q35057667 | Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland |
| Q35770239 | Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling |
| Q89587291 | Neuropilin: Handyman and Power Broker in the Tumor Microenvironment |
| Q64252020 | Neuropilins Controlling Cancer Therapy Responsiveness |
| Q27024032 | Neuropilins and liver |
| Q38040614 | Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity |
| Q64275592 | Neuropilins in the Context of Tumor Vasculature |
| Q38161356 | Neuropilins: a new target for cancer therapy |
| Q26998786 | Neuropilins: expression and roles in the epithelium |
| Q30360377 | Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma |
| Q92508947 | Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway |
| Q57423198 | Pancreatic cancer |
| Q50985118 | Physiological Signaling and Structure of the HGF Receptor MET. |
| Q38341297 | Receptor activity modifying protein‐3 mediates the protumorigenic activity of lysyl oxidase‐like protein‐2 |
| Q85053333 | Role of Neuropilin-1 and its expression in Egyptian Acute Myeloid and Acute Lymphoid Leukemia patients |
| Q39839983 | Role of c-Met in cancer: emphasis on lung cancer |
| Q36936042 | Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker? |
| Q37072227 | Semaphorins and their receptors in lung cancer. |
| Q90999542 | Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects |
| Q35930489 | Specific Neuropilins Expression in Alveolar Macrophages among Tissue-Specific Macrophages |
| Q36908890 | Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion |
| Q90590077 | Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis |
| Q47160963 | Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer |
| Q38256958 | The emerging role of class-3 semaphorins and their neuropilin receptors in oncology |
| Q90399257 | The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer |
| Q24316500 | The role of neuropilins in cell signalling |
| Q38929961 | The role of the semaphorins in cancer |
| Q37200576 | The semaphorins: versatile regulators of tumour progression and tumour angiogenesis |
| Q33573324 | VEGF targets the tumour cell |
| Q33645250 | Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells |
| Q54786000 | miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. |
Search more.